{
    "id": 29114,
    "fullName": "CIC inact mut",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "CIC inact mut indicates that this variant results in a loss of function of the Cic protein. However, the specific amino acid change has not been identified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 23152,
        "geneSymbol": "CIC",
        "terms": [
            "CIC",
            "MRD45"
        ]
    },
    "variant": "inact mut",
    "createDate": "12/10/2018",
    "updateDate": "12/10/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15421,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a preclinical study, the presence of inactivating CIC mutations was associated with resistance to Mekinist (trametinib) in a panel of cancer cell lines (PMID: 30115695).",
            "molecularProfile": {
                "id": 31033,
                "profileName": "CIC inact mut"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 13210,
                    "pubMedId": 30115695,
                    "title": "RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30115695"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31033,
            "profileName": "CIC inact mut",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}